No Borders, Inc. (OTC:NBDR)
To download this report as a PDF click: NBDR End Of Year Review January 2020
No Borders, Inc. had a very productive 2019 with multiple PR’s, investor relation opportunities, sales and engagement events, and quarter over quarter growth. From the standpoint of company credibility, No Borders, Inc has developed a culture of honesty by only sharing information about completed deals.
For a list of available analytical products on No Borders, Inc., please visit https://randomanalysts.wordpress.com/stocks/no-borders-inc-dd/
No Borders Inc has exhibited a steady growth rate of over 30% per quarter over the last year, with the average for the previous three quarters being roughly 76%. This trend shows some signs of weakening due to the reduced quarterly growth, 1Q19 growth was 100% over FY 18, 2Q19 was 94% over 1Q, and 3Q19 was 34% over 2Q. This may indicate current market saturation for targeted demographics and marketing campaigns and may highlight a need to expand into new marketing areas, technology, or verticals.
No Borders, Inc has continued to demonstrate a willingness to protect their intellectual property by filing trademarks and patents for what they have developed. The analyst was only able to locate eight filings within the trademark and patent system. It is unclear at this time how many filing No Borders has applied for or been approved for.
As No Borders continues to grow, it may become advisable for the company to publish a running list or tally of applied or approved patents and trademarks. In addition to this product updates for any released and protected software and services.
Over the last 12 months, No Borders has released 32 individual PRs about ongoing operations. These releases cover a wide verity of actions taken by No Borders to include distribution rights, product offerings, and company appointments.
For a complete list of Public Releases visit: https://www.otcmarkets.com/stock/NBDR/news
In addition to the PR’s, No Borders has also released over 12 hr of video content spread over 26 videos posted on the company’s YouTube channel, which has reached over 63,000 interested individuals curious about this company and its products. These videos, hosted by No Borders CEO Joseph Snyder can be found at https://www.youtube.com/channel/UCbs5ao29pXY63zwO3eQu6mw/featured
No Borders, Inc. SEC Reg 1A
In late September 2019, No Borders, Inc requested and was granted permission from the SEC to conduct a Reg 1A filing for the sale of 300 million shares of common stock at a par value of $0.01 per share. The goal of this sale, according to No Borders, is to raise capital for company scaling.
The amended Reg 1A can be found at: https://www.otcmarkets.com/filing/html?id=13692800&guid=v1GjUeuR5lhTMth
Previously conducted analysis can be found at: https://randomanalysts.wordpress.com/2019/10/08/catching-up-on-no-borders-inc-otcnbdr/
Interview with CEO Joseph Snyder in regards to Reg 1A can be found at: https://youtu.be/z58PDi5xIFs
Projections for 2020
Moving forward into 2020, No Borders, Inc. is projected to have additional growth in regards to branding, reach, and customer sales. Based on FY19 quarterly revenue, No Borders expected annual report might be between $380-$430 thousand in revenue. This estimate is based on open-ended statements by No Borders CEO and to date activities. A critical factor in the continued viability of No Borders as a company will be its ability to maintain a positive growth rate. The next investor milestone for No Borders will be a cash positive quarterly report. Without taking into account the expected common stock share issuances, but including the historic growth rate, it can be expected that No Borders may have a cash positive quarterly report with in the next 3 to 5 quarters.
No Borders 2020 Strategic Plan
On November 7th, No Borders, Inc released their vision for FY 2020. Taking a look at the 2020 road map as laid out by Mr. Snyder, we see four significant action points, two supporting points, and two pivoting points. These eight points are listed below.
Significant action points
- SEC Reg 1A
- Hire auditors to conduct two-year company review
- Become a fully SEC reporting company
- Uplisting OTCQB
Supporting action point
- Bring on eight new advisors
- Intellectual Property
- Selling current verticals
- Acquire new verticals
View NBDR 2020 Road Map video at: https://www.youtube.com/watch?v=HCQ2exhztbU
Full analysis for NBDR 2020 Road Map can be found at: https://randomanalysts.wordpress.com/stocks/no-borders-inc-dd/assessment-of-nbdr-2020-road-map-video/
In the final analysis, No Borders has had a fantastic year. Their desire to only bring done deals to investors and their commitment to being “different by design” has infected every part of this great company. As they move into the new year, you can expect No Borders, Inc to continue its established tradition of open and honest company growth through testing and evaluation.
This concludes the Year-End Review for No Borders, Inc. For assessments or analysis production information, contact the author at email@example.com.
About No Borders Inc.
No Borders, Inc. (OTC:NBDR) is a multifaceted corporation specializing in the acquisition, creation, and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority across its portfolio of assets. The Companys portfolio of brands includes:
- No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets. (www.NoBordersNaturals.com)
- No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (www.MediDentSupplies.com).
- No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (www.NoBordersLabs.com).
- www.CBDLabChain.com which is a powerful tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate Of Authority (COA) on a blockchain technology platform. With a goal to provide consumers with peace of mind, No Borders Labs designed CBD LabChain to record THC, CBD and other lab test data variants with those results easily accessible via QR code linkage as well as a clear Results Guaranteed With Blockchain icon, which can be integrated directly into individual product labels.
No Borders, Inc. is headquartered in Arizona with resources in the U.S., South America, Asia, and Europe. For more information, visit the Company’s website at www.NBDR.co.
Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice. Separate from the factual content of our articles about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. We did not make an independent investigation or inquiry as to the accuracy of any information published by the Company, or other firms. The author relied solely upon information published by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
This report or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This publication does not take into account the investment objectives, financial situation, or particular needs of any particular person. This publication does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. We are not registered as a securities broker-dealer or an investment adviser with FINRA, the U.S. Securities and Exchange Commission, or with any state securities regulatory authority.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO,LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
Information, opinions, or recommendations contained in this report are submitted solely for informational purposes. The information used in statements of fact made has been obtained from sources considered reliable, but we neither guarantee nor represent their completeness or accuracy. Such information and the opinions expressed are subject to change without notice. This research report is not intended as an offering or a solicitation of any offer to buy or sell the securities mentioned or discussed. The firm, its principles, or the assigned analyst may or may not own or trade shares, options, or warrants of this covered Company.